Newsbenzinga
Telix Makes $1.65 Billion Bet on ITM to Build a Radiopharma Powerhouse
· Published
Article summary
Telix Pharmaceuticals acquires ITM Isotope for $1.65B to create a radiopharmaceutical leader. Here is what investors need to know.
An excerpt from the original article.
Comments —
Loading comments…